Past-Presidents

Gregory N. Fuller

Gregory N. Fuller

2011-12

Born: Houston, Texas

Academic Degrees

  • BS: Texas A&M University, College Station, Texas 1976
  • PhD: The University of Texas Graduate School of Biomedical Sciences, Houston, Texas 1983
  • MD: Baylor College of Medicine, Houston, Texas 1987

Academic Positions

  • 1982 - 1983 Assistant Instructor of Neurobiology and Anatomy, The University of Texas Medical School at Houston
  • 1992 - Assistant Professor of Pathology, then Associate Professor Pathology (1998) and Professor of Pathology (2003), MD Anderson Cancer Center, Houston, Texas

Training

  • Duke University

Selected Career Highlights

  • Chief, Section of Neuropathology (1998-present); Director, Nucleic Acid Hybridization Laboratory (1998-2005); Director, Tissue Microarray and Automated Image Acquisition Core Laboratories (2001-present); and Chief, Section of Immunocytochemistry (2001-2005) at MD Anderson Cancer Center, Houston, Texas.

  • Initial discovery in 1999, together with long-time collaborator Wei Zhang, of the reactivation of IGFBP2 in high-grade gliomas, and subsequent elucidation of the pathobiology of IGFBP2 and its principal binding partner, IIp45, in gliomas and other human malignancies over the subsequent 10 years, encompassing over 20 publications with multiple papers in the Proceedings of the National Academy of Sciences, Cancer Research, and the Journal of Biological Chemistry.

  • He and Wei Zhang were the first investigators to apply the nascent approach of transcriptome profiling to the study of brain tumor biology and molecular classification in the mid-1990's. For this work they received the Lucien J. Rubinstein award for Neuro-Oncology in 2000.

  • First laboratory to employ tissue microarray technology to facilitate the rapid evaluation of brain tumor biomarkers.

  • Together with collaborator Eric Holland (Memorial Sloan-Kettering Cancer Center), conducted the first glioma modeling studies on controlled in vivo oncogene expression using the combined transgenic/somatic gene transfer RCAS/tva system. The results of the initial seminal studies were published in Nature Genetics, Genes & Development, and the American Journal of Pathology.

  • Over 200 peer-reviewed publications and over 40 books, mostly in the areas of neuropathology, immunocytochemistry, genetics and new molecular techniques.

  • Co-author of two major books: Practical Review of Neuropathology (with JC Goodman); and Genomic and Molecular Neuro-Oncology (with W. Zhang).

  • Co-author (with JC Goodman) of the manual Contemporary Neuropathology, in its 12th edition.

  • Member of 10 Editorial Boards including:

    • Advances in Anatomic Pathology (Neuropathology Section Editor)
    • American Journal of Surgical Pathology
    • Archives of Pathology
    • Journal of Neuropathology and Experimental Neurology
    • Modern Pathology
    • Neuro-Oncology
    • Pathology
  • A famous, world-class teacher and educator with hundreds of invited lectures, conferences and recipient of multiple teaching awards from the Baylor College of Medicine and the University of Texas Medical School.

  • President, Houston Neurological Society (two terms).

  • Member of virtually every USCAP Committee.

  • Has received multiple awards from neurology organizations such as the American Association of Neuropathologists and the Radiological Society of North America.

  • Recipient of 20 competitive grants and contracts.

  • Invests in his community through service and support of organizations such as the YMCA Partner Program and their mission to make programs available to disadvantaged youth.

  • Is a confirmed "gym rat" (body sculpting) and a firm believer in John Locke's "sound mind in a sound body".

About

view more